Tonix Pharmaceuticals (TNXP) Misses Q3 EPS by 2c

Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q3 EPS of ($0.71), $0.02 worse than the analyst estimate of ($0.69).

For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal